International Patent: EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERS SECONDARY TO RETINAL VEIN OCCLUSION

GENEVA, July 1 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/059488) for “EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERS SECONDARY TO RETINAL VEIN OCCLUSION”. With publication no. WO/2026/128860, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/17

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....